340B Background and Trends

The 340B Drug Pricing Program has experienced extraordinary growth over thepast 10 years, propelled by a potent mixture of regulatory, […]

In 2014, the Alliance for Integrity and Reform of 340B (AIR340B) published a paper highlighting the negative impact the growth

Morning Consult ran a poll, on behalf of AIR340B, focusing on support for andimpacts of the 340B Drug Pricing Program.

The 340B Drug Discount Program has come under increased scrutiny in recent years from government agencies and others who note

Since its inception, the 340B Drug Discount Program has been the subject of countless researchstudies, white papers, and analyses looking

In February 2016, Apexus made available data on total drug sales through the 340B program from 2005 through 2015. These

The 340B program has undergone significant changes in recent years coinciding with a period of dramatic program growth. This growth

In 1990 Congress created the Medicaid Drug Rebate Program which regulated the prescription drug manufacturer ceiling price for drugs provided

The Affordable Care Act changed the landscape of American health care in many significant ways, with much of it receiving

Congress established the 340B Drug Discount Program (340B) in 1992 to support access to prescription medicines for medically underserved populations.